Zydus Lifesciences Shares Slump 5% as Unit Receives Ten Observations
Shares of Zydus Lifesciences were trading in the red and 5% lower on 24 April after the company’s injectables production plant received ten observations from...
Tag : US Food and Drug Administration (USFDA)
Sun Pharmaceutical Shares Slip 3% as Unit Receives OAI Label from USFDA
Shares of Sun Pharmaceutical Industries Ltd were trading in the red and 3% lower on 12 April after the USFDA issued an ‘official action indicated’...
Alembic Pharmaceuticals Shares Surge 4% on Tentative USFDA Approval
Shares of Alembic Pharmaceuticals Ltd were trading 4% higher on 1 April after the company announced receiving tentative approval from USFDA. In its regulatory filing,...
Aurobindo Pharma Shares Slip 2% as USFDA Raises Procedural and Cleanliness Issues
Shares of Aurobindo Pharma Ltd were trading in red and 2% lower on 15 March after the USFDA raised procedural and cleanliness issues at the...
Torrent Pharma Shares Hit 52-Week High on a Successful USFDA Inspection
Shares of Torrent Pharmaceuticals Ltd hit a 52-week high of Rs 2,742.60 on 6 March after the company announced receiving EIR from the USFDA. In...
Dr Reddy’s Shares Hit 52-Week High on Receiving VAI Status from USFDA
Shares of Dr Reddy’s Laboratories Ltd hit a 52-week high of Rs 6,388.45 on 12 February after USFDA (US Food and Drug Administration) cleared its...
Piramal Pharma Shares Slump 5% as US Facility Receives 3 Observations
Shares of Piramal Pharma Ltd slumped 5% on 8 February after the company said that its Riverview facility in the US was under inspection by...
Aurobindo Pharma Shares Sink 5% as USFDA Issues 9 Observations
Shares of Aurobindo Pharma plummeted 5% on 5 February after the pharma major halted production at one unit after USFDA issued 9 observations for its...
Cipla Receives US FDA Letter Flagging Data Issues at MP Unit, Stock Emerges Top Nifty Losers
On November 23, 2023, Cipla, a prominent pharmaceutical company, witnessed a nearly 7% decline in its stock following the issuance of a warning letter by...
Aurobindo, Alembic Shares Slide as They Recalled Drugs from US Markets
Alembic Pharmaceuticals and Aurobindo Pharma issued voluntary recalls of different products in the US markets because of quality issues and manufacturing deficiencies, according to the...